Has Anwar Mack, MD received payments from drug or device companies?

Yes. Drug and device makers reported $32,477 in general payments to Anwar Mack, MD across 436 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anwar Mack, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anwar Mack, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anwar Mack, MD

Pain Medicine · Reno, NVNPI 1184010597

Payments from drug & device makers

$32,477in general payments, 2019–2025

Across 436 payments — averaging $74.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$19K
Boston Scientific$2K
Pacira Pharmaceuticals Incorporated$1K
Nevro Corp.$1K
Relievant Medsystems, Inc.$1K
SPR Therapeutics, Inc$1K
plus $7K from 39 others

What the payments were for

Grants$7,50023%
Travel & lodging$11,43335%
Food & beverage$13,54442%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	137	$18,579
Boston Scientific	29	$1,860
Pacira Pharmaceuticals Incorporated	9	$1,354
Nevro Corp.	28	$1,200
Relievant Medsystems, Inc.	9	$1,118
SPR Therapeutics, Inc	7	$1,099
Si-bone, Inc.	11	$1,049
Stimwave Technologies Incorporated	6	$882
AbbVie(2 entities)	48	$784
Neuronetics, Inc.	2	$627
Saluda Medical Americas, Inc.	27	$620
Tersera Therapeutics LLC	12	$367
Abbott	6	$332
Nalu Medical, Inc.	7	$300
Pfizer	13	$239
Teva Pharmaceuticals USA, Inc.	9	$222
Vertos Medical, Inc.	2	$150
Amgen	4	$133
Biodelivery Sciences International, Inc.	9	$132
Collegium Pharmaceutical, Inc.	6	$123
AstraZeneca	1	$110
Painteq LLC	2	$96
Vertex	4	$95
Scilex Pharmaceuticals Inc.	5	$89
Bioventus LLC	3	$87
Pacira Therapeutics, Inc.	4	$79
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$78
Stryker	2	$70
Saol Therapeutics Inc.	1	$65
Sanofi-aventis U.S. LLC	2	$65
GRT US Holding, Inc.	3	$64
Globus Medical	2	$54
IBSA Pharma Inc.	2	$48
Lilly USA, LLC	3	$44
Averitas Pharma Inc.	2	$37
Alnylam Pharmaceuticals Inc.	2	$35
Biohaven Pharmaceutical Holding Company Ltd.	2	$34
Merz North America, Inc.	2	$31
Baudax Bio Inc.	2	$26
Biohaven Pharmaceuticals, Inc.	1	$22
Redhill Biopharma Inc.	1	$18
Curonix LLC	1	$16
Eisai Inc.	1	$16
Convatec Inc.	1	$16
Forte Bio-pharma LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,477 in reported general payments places this provider in the 95th percentile of 101 pain medicine providers in Nevada.

See all pain medicine providers in Nevada →

Medicare billing

Part B allowed, 2024

$756,089

Medicare patients

964

Services billed

36,485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	143	$3,243
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	21	$2,710
Pregabalin	46	$1,809
Oxycodone Hcl	94	$1,317
Duloxetine Hcl	33	$1,028
Gabapentin	70	$1,025
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	35	$800
Morphine Sulfate ErMorphine Sulfate	26	$436
Tizanidine Hcl	38	$419
Hydromorphone Hcl	12	$209
Tramadol Hcl	44	$198
Methadone Hcl	14	$181
Cyclobenzaprine Hcl	22	$103
Meloxicam	28	$59
Alprazolam	31	$41

Paid to pharmacies, not to this prescriber.

Other pain medicine in Reno

Denis PattersonReno$1.3M
Jonathan BurnsReno$20K
Ross JensonReno$19K
Michael GyorfiReno$17K
Jacob BlakeReno$8K
Jeffery MuirReno$6K
Seneca StormReno$2K
Rainer VogelHenderson$349K
Andrew KimLas Vegas$69K
John DimuroPahrump$44K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →